Relationship between Hyperglycemia and Diabetic Glomerulosclerosis

  • Celia S. Levitz
  • Sondra R. Hirsch
  • Eli A. Friedman


Uremia in diabetics as a result of progressive glomerulosclerosis accounts for one fourth of patients newly accepted in maintenance hemodialysis and renal transplant programs in the United States. Convincing evidence indicates that degenerative vasculopathy in the diabetic eye and glomerulus are a direct result of hyperglycemia and a function of duration of diabetes. Based on animal models of diabetes and clinical observations over the past few years, the thesis that careful control of blood glucose will preempt development of vasculopathy and correct abnormalities of intermediate metabolites and hormonal disturbances is increasingly accepted. Development of simplified methods of self-monitoring of blood glucose and of lightweight battery-powered insulin infusion systems has permitted study of nearly euglycemic diabetics for a year or longer. It can be anticipated that the lessons learned in recent advances in diabetic management will in sum improve well-being and retard development of vasculopathy. Mogenson,1 for example, has shown that control of hypertension in azotemic diabetics retards deterioration of glomerular filtration at the rate of 9 ml/min/year. Our preliminary experience suggests that, in addition to reduction of blood pressure, morbidity in renal transplanted and uremic diabetics can be further reduced by incorporating self-monitoring of blood glucose into the treatment regimen.


Blood Glucose Diabetic Retinopathy Peritoneal Dialysis Renal Transplant Recipient Glomerular Basement Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mogenson CE: Diabetes and hypertension. Lancet 1: 308, 1979.Google Scholar
  2. 2.
    Service FJ, Molnar GD, Rosevear JW: Mean amplitude for glycemic excursion. A measure of diabetic instability. Diabetes 19: 644, 1970.PubMedGoogle Scholar
  3. 3.
    Mauer SM: Development of diabetic vascular lesion in normal kidneys transplanted into patients with diabetes. N Engl J Med 295: 916, 1976.PubMedCrossRefGoogle Scholar
  4. 4.
    Koenig RJ, Peterson CM, Jones RH, et al: Correlation of glucose regulation and hemoglobin Ai, in diabetes mellitus. N Engl J Med 295: 471, 1979.Google Scholar
  5. 5.
    Culebras A, Alio J, Herrera J, et al: Effect of an aldolase reductase inhibitor on diabetic peripheral neuropathy. Preliminary Reports. Arch Neural 38: 133, 1981.CrossRefGoogle Scholar
  6. 6.
    Gabbay KH: Hyperglycemia, polyol metabolism, and complication of diabetes mellitus. Ann Rev Med 26: 521, 1975.PubMedCrossRefGoogle Scholar
  7. 7.
    Takajakura E, LaKamoto S, Goshido E, et al: Onset and progression of diabetic glomerulosclerosis. A prospective study based on serial renal biopsies. Diabetes 24: 1, 1975.CrossRefGoogle Scholar
  8. 8.
    Price RG, Spiers RG: Studies on the metabolism of the renal glomerular basement membrane. Turnover measurements in the rat with the use of radio labed amino acid. J Biol Chem 252: 8597, 1977.PubMedGoogle Scholar
  9. 9.
    Osterby R: Quanitative electron microscopic studies of glomerulus in diabetes mellitus, in Ditzel J, Lewis DH (eds): Microcirculatory Approach to Current Therapeutic Problems: Lung in Shock, Organ Transplantation, Diabetic Microangiopathy. Basel, New York, Karger, 1971, p 142.Google Scholar
  10. 10.
    McVerry BA, Fisher C, Hopp A, et al: Production of pseudo diabetic glomerular changes in mice after repeated injections of glucos ylated proteins. Lancet 1: 738, 1980.PubMedCrossRefGoogle Scholar
  11. 11.
    Joyner WI, Mayhan WG, Johnson RL, et al: Microvascular alterations develop in Syrian hamsters after induction of diabetes mellitus by streptozotocin. Diabetes 30: 93, 1981.PubMedCrossRefGoogle Scholar
  12. 12.
    Ditzel J, Duckers J: The bulbar conjunctival vascular bed in diabetic children. Acta Paediatr 46: 535, 1957.PubMedCrossRefGoogle Scholar
  13. 13.
    Weber CJ, Silva FG, Hardy MA, et al: Effects of islet transplantation on renal function and morphology of short and long term diabetic rats. Transplant Proc 11: 549, 1979.PubMedGoogle Scholar
  14. 14.
    Mauer SM, Steffes MW, Sutherland DER, et al: Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes 24: 280, 1975.PubMedCrossRefGoogle Scholar
  15. 15.
    Silva FG, Weber CJ, Pirani CH, et al: Effects of islet transplantation of glomerular basement membrane thickness and proteinuria in diabetic Lewis rats. Diabetes 28: 426, 1978.Google Scholar
  16. 16.
    Mauer SM, Sutherland DER, Steffes MW, et al: Pancretic islet transplantation effects on the glomerular lesions of experimental diabetes in the rats. Diabetes 23: 748, 1974.PubMedGoogle Scholar
  17. 17.
    Rasch R: Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Diabetologia 16: 125, 1979.PubMedCrossRefGoogle Scholar
  18. 18.
    Bretzel RG, Breidenbach C, Mofmann J, et al: Islet transplantation in experimental diabetes of the rat. Rate of regression in diabetic kidney lesions after iosgenic islet transplantation: Quantitative measurements. Horm Metab Res 11: 200, 1979.PubMedCrossRefGoogle Scholar
  19. 19.
    Leo SM, Bressler R: Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes 30: 106, 1981.CrossRefGoogle Scholar
  20. 20.
    Champion MC, Shepard GAA, Rodger NW, et al: Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes 29: 206, 1980.PubMedGoogle Scholar
  21. 21.
    Gliedman MI, Tellis VA, Soberman R, et al: Long term effect of pancreatic transplant function in patients with advanced JODM. Diabetes Care 1: 1, 1978.PubMedCrossRefGoogle Scholar
  22. 22.
    Tamborlane WV, Sherwin R, Gene M, et al: Restoration of normal lipid and amino acid metabolism in diabetic patients treated with a portable insulin infusion pump. Lancet 1: 1258–1261, 1979.PubMedCrossRefGoogle Scholar
  23. 23.
    Tamborlane WV, Koursto V, Mendier R, et al: Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump, Diabetes 28: 785–788, 1979.PubMedGoogle Scholar
  24. 24.
    Exchwege E, Job D, Guy OL, et al: Delayed progression of diabetic retinopathy by divided insulin administration: A future follow-up. Diabetologia 16: 13, 1979.CrossRefGoogle Scholar
  25. 25.
    Irsigler K, Kritz H, Najemnik C, et al: Reversal of florid diabetic retinopathy. Lancet 1068, 1979.Google Scholar
  26. 26.
    Avram MM, Slater PA, Fein PA, et al: Comparative survival of 673 patients with chronic uremia treated with renal transplantation and maintenance hemodialysis. Trans Am Soc Artif Intern Organs 25: 391, 1979.PubMedCrossRefGoogle Scholar
  27. 27.
    Peterson CM, Jones RL: Hematologic alterations in diabetes mellitus. Amer J Med 70: 339, 1981.PubMedCrossRefGoogle Scholar
  28. 28.
    Mauer SM, Steffes MW, Agar S, et al: The effects of Goldblatt hypertension on the development of glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738, 1978.PubMedCrossRefGoogle Scholar
  29. 29.
    Steffes MW, Brown DM, Mauer SM: Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 25, 1978.CrossRefGoogle Scholar
  30. 30.
    Berkman J, Rifkin H: Unilateral nodular diabetic glomerulosclerosis (Kimmerstel-Wilson): Report of a case. Metab Clin Exp 22: 715, 1973.PubMedCrossRefGoogle Scholar
  31. 31.
    Behrindt T, Duane TD: Unilateral complications in diabetic retinopathy. Trans Am Acad Ophth Otol 74: 28, 1970.Google Scholar
  32. 32.
    Pirart J: Diabetes Mellitus and its degenerative complications: A prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1:(part I)168–188, (part II ) 252–263, 1978.Google Scholar
  33. 33.
    Rubin J, Oreopoulos DG, Blair RBG, et al: Chronic peritoneal dialysis in the management of diabetes with terminal renal failure. Nephron 19: 265, 1977.PubMedCrossRefGoogle Scholar
  34. 34.
    Flynn CT, Mibbana J, Dohrman B: Advantages of continuous ambulatory peritoneal dialysis to the diabetic with renal failure. Proc EDTA 16: 184, 1979.Google Scholar
  35. 35.
    Jovanovic L, Peterson CM, Savena BB, et al: Feasibility of maintaining normal glucose profiles in insulin dependent pregnant diabetic women. Am J Med 68: 105, 1980.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • Celia S. Levitz
    • 1
  • Sondra R. Hirsch
    • 1
  • Eli A. Friedman
    • 1
  1. 1.Department of MedicineDownstate Medical CenterBrooklynUSA

Personalised recommendations